Re: Factor V Leiden and OCs

From: ainsron@msn.com
Mon Nov 6 10:06:59 2000


Thanks for the information.

>Found this on --Syllabus Seminar at San Juan -Feb 2000 Hope it comes out
>Ok Scan-OCR-Word-copy-paste
>
>ADVANCES IN MOLECULAR GENETICS THAT IMPACT OB/GYN PRACTICE
>Aubrey Milunsky, MB.B.Ch.,D.Sc.,F.R.C.P.,F.A.C.M.G.,D.C.H.
>SPECIFIC GENES AND THEIR MUTATIONS AS RISK FACTORS FOR VENOUS OR
>ARTERIAL THROMBOSIS
>Gene mutations that cause clots to form in veins or arteries or
>predispose individuals to such complications are responsible for a whole
>range of such disorders called the inherited thrombophilias. Genetic
>disorders involving platelets, protein C and S and fibrinogen,
>homocysteine as well as genes encoding antithrombin may all result in
>vascular thrombosis. The prevalence of defects in most of these factors
>appears to be relatively low, exceptions being venous thombosis due to
>mutations in the Factor V Leiden gene and the specific mutation (20210A)
>in the prothrombin gene, both of which are very significant causal or
>predisposing factors in thrombosis requiring special attention.
>Mutations in the Factor V Leiden Gene
>Thrombosis may occur as strokes, deep vein thrombosis in the legs with
>or without pulmonary embolism, or in myocardial infarction.
>· The most common hereditary blood clotting disorder is due to a
>mutation in the Factor V Leiden gene.
>· Autosomal dominant mode of inheritance.
>· About 5.27% Caucasians have a mutation in this gene.
>· Ethnic differences exist in the carrier frequency of Factor V Leiden
>deficiency:
>· In Hispanic-Americans (2.21 %)
>· African-Americans (1.23%)
>· Asian-Americans (0.45%)
>· Native-Ameri cans (1.25%)
>· Risks of thrombosis - 7-fold in heterozygotes 80- fold in homozygotes
>· Risks of venous thromboembolism increase several hundred-fold in women
>homozygous for this mutation and using oral contraceptives,
>· About 20% of patients with a first episode of deep vein thrombosis
>have this Factor V missense mutation.
>· About 60% with recurrent thrombosis or pregnancy-associated
>thrombosis/embolism have this mutation.
>· Since the gene for Factor V Leiden and the antithrombin III gene are
>both located on the long arm of chromosome 1, these two deficiencies are
>frequently co-inherited!
>· Adverse Pregnancy Outcome Increased risk for severe preeclampsia (risk
>about double in women heterozygous for this mutation)
>· Increased frequency reported of recurrent pregnancy loss, recurrent
>intrauterine fetal deaths, intrauterine growth retardation, and
>increased likelihood of placental infarction
>· Women with the HELLP syndrome (hemolysis, elevated liver enzymes, low
>platelets) have a higher incidence of Factor V LeidE mutations,
>· In about 70% with this mutation, a second "hit" or factor is necessary
>for thrombosis to occur. Second "hits" include,
>- oral contraceptive use
>- surgery
>- trauma
>- homozygosity for this mutation
>- protein C deficiency
>- protein S deficiency
>- antithrombin III deficiency
>- presence of lupus anticoagulant
>- hyperhomocystinemia
>· Do DNA analysis for the Factor V Leiden mutation in
>- Patients with previous deep vein thrombosis
>- Those with family history of early age stroke
>- Patients with thromboembolism
>- Patients with hyperhomocystinuria
>· Clinical implications and risk management following discovery of
>Factor V Leiden mutation
>- Inquire about family history (including partners of deep
>veinthrombosis, early strokes, thromboembolism, early cardiac
>infarction.
>- Offer DNA analysis for this mutation if family history positive for
>any of these problems.
>- Also test women with unexplained recurrent pregnancy loss, stillbirth
>> 10% placental infarction and those with preeclampsia.
>- Avoid oral contraceptives. {Avoid liability and document
>advice).
>- Some patients may need long-term anticoagulant therapy. - Give
>optimal antithrombotic prophylaxis following surgery (including
>C-Section), following pregnancy and if there will be prolonged
>immobility.
>- Watch for a familv history of deep vein thrombosis. If positive
>history, test patient for Factor V Leiden mutation and recommend family
>be tested. Since about 1 in 20 women carry the Factor V Leiden
>mutation, consideration should be given to screening all Caucasians in
>the preconception period.
>· Inquire about family hx (including partners) of DVT, early strokes,
>thromboembolism, early cardiac infarction."
>
>--
>"Do not take life too seriously. You will never get out of it alive."
>
>Marianne Williamson
>

--
Ronald E. Ainsworth, MD




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 04:46:22 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.